PharVision Advisers’s SiriusPoint SPNT Stock Holding History

PharVision Advisers’s Portfolio SPNT Stock Details SPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,568	Closed	-$183K	–	419
2025 Q1	$183K	Buy	+10,568	New	+$158K	0.25%	210

Other funds holding SPNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.65B AUM 47.79% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

PharVision Advisers's SPNT Position: Q2 2025 in Review

PharVision Advisers sold out of SiriusPoint (SPNT) in Q2 2025, closing a stake of 10,568 shares — an estimated $183K sold.

PharVision Advisers first reported a position in SPNT in Q1 2025 and held it in 1 quarter. The position peaked at $183K in Q1 2025. 213 funds tracked by Wall St. Rank hold SPNT as of Q2 2025.

PharVision Advisers reported no remaining SiriusPoint position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 10,568 SiriusPoint shares in Q2 2025, an estimated $183K.
PharVision Advisers first reported a position in SiriusPoint in Q1 2025 and held it in 1 quarter.
PharVision Advisers's SiriusPoint position peaked at $183K in Q1 2025.
213 funds tracked by Wall St. Rank held SiriusPoint as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.